In addition, some researchers asserted that new treatment modalities such as specific monoclonal antibodies, TSH-R antagonists, and other immunomodulatory agents show a promising outcome for Graves’ ophthalmopathy patients19. Here, TSHR is linked to Graves ophthalmopathy.